![](/images/general/no_picture/200_user.png)
Carl D Friedman
Examiner (ID: 6600)
Most Active Art Unit | 3504 |
Art Unit(s) | 2403, 2407, 3635, 3621, 3505, 3632, 3504 |
Total Applications | 1006 |
Issued Applications | 891 |
Pending Applications | 6 |
Abandoned Applications | 109 |
Applications
Application number | Title of the application | Filing Date | Status |
---|---|---|---|
Array
(
[id] => 12621687
[patent_doc_number] => 20180099059
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => METHODS AND APPARATUS FOR CELL TRACKING AND MOLECULAR IMAGING
[patent_app_type] => utility
[patent_app_number] => 15/729164
[patent_app_country] => US
[patent_app_date] => 2017-10-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5393
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 68
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15729164
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/729164 | METHODS AND APPARATUS FOR CELL TRACKING AND MOLECULAR IMAGING | Oct 9, 2017 | Abandoned |
Array
(
[id] => 12621684
[patent_doc_number] => 20180099058
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-12
[patent_title] => Ultrasound Gel Composition
[patent_app_type] => utility
[patent_app_number] => 15/719018
[patent_app_country] => US
[patent_app_date] => 2017-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1514
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15719018
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/719018 | Ultrasound Gel Composition | Sep 27, 2017 | Abandoned |
Array
(
[id] => 14621899
[patent_doc_number] => 20190224317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => BIOPHOTONIC COMPOSITIONS AND METHODS FOR REDUCING SCARRING
[patent_app_type] => utility
[patent_app_number] => 16/333707
[patent_app_country] => US
[patent_app_date] => 2017-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15655
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333707
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333707 | BIOPHOTONIC COMPOSITIONS AND METHODS FOR REDUCING SCARRING | Sep 21, 2017 | Abandoned |
Array
(
[id] => 12259546
[patent_doc_number] => 20180078742
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-03-22
[patent_title] => 'Radiopaque Composite Wire for Medical Applications and Method of Making a Radiopaque Composite Wire'
[patent_app_type] => utility
[patent_app_number] => 15/709680
[patent_app_country] => US
[patent_app_date] => 2017-09-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 5963
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15709680
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/709680 | Radiopaque Composite Wire for Medical Applications and Method of Making a Radiopaque Composite Wire | Sep 19, 2017 | Abandoned |
Array
(
[id] => 14744045
[patent_doc_number] => 20190255196
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-22
[patent_title] => NOVEL LIPOSOMAL GADOLINIUM (GD) CONTRAST AGENT "NMRX" FOR T1-MRI
[patent_app_type] => utility
[patent_app_number] => 16/333832
[patent_app_country] => US
[patent_app_date] => 2017-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -28
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16333832
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/333832 | Liposomal gadolinium (GD) contrast agent "NMRX" for T1-MRI | Sep 14, 2017 | Issued |
Array
(
[id] => 14409803
[patent_doc_number] => 20190170745
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-06
[patent_title] => INTERNALLY FIXED LIPID VESICLE
[patent_app_type] => utility
[patent_app_number] => 16/322014
[patent_app_country] => US
[patent_app_date] => 2017-07-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6823
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16322014
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/322014 | INTERNALLY FIXED LIPID VESICLE | Jul 27, 2017 | Pending |
Array
(
[id] => 16769819
[patent_doc_number] => 10980902
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-20
[patent_title] => Bi-DOTA complex-loaded dendritic polymer nanoparticles
[patent_app_type] => utility
[patent_app_number] => 16/317757
[patent_app_country] => US
[patent_app_date] => 2017-07-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 11
[patent_no_of_words] => 13627
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16317757
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/317757 | Bi-DOTA complex-loaded dendritic polymer nanoparticles | Jul 13, 2017 | Issued |
Array
(
[id] => 14306551
[patent_doc_number] => 20190142979
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-05-16
[patent_title] => CONTRAST MEDIUM AND METHODS INVOLVED IN PREPARATION FOR THE DETERMINATION OF PATENCY OF CONDUITS
[patent_app_type] => utility
[patent_app_number] => 16/315658
[patent_app_country] => US
[patent_app_date] => 2017-07-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16315658
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/315658 | CONTRAST MEDIUM AND METHODS INVOLVED IN PREPARATION FOR THE DETERMINATION OF PATENCY OF CONDUITS | Jul 6, 2017 | Abandoned |
Array
(
[id] => 16009393
[patent_doc_number] => 20200179539
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-11
[patent_title] => Contrast Agents and Methods of Making the Same for Spectral CT That Exhibit Cloaking and Auto-Segmentation
[patent_app_type] => utility
[patent_app_number] => 16/311105
[patent_app_country] => US
[patent_app_date] => 2017-06-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8994
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -30
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16311105
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/311105 | Contrast Agents and Methods of Making the Same for Spectral CT That Exhibit Cloaking and Auto-Segmentation | Jun 21, 2017 | Abandoned |
Array
(
[id] => 12126178
[patent_doc_number] => 20180009763
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-11
[patent_title] => 'CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING'
[patent_app_type] => utility
[patent_app_number] => 15/629068
[patent_app_country] => US
[patent_app_date] => 2017-06-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35692
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15629068
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/629068 | Contrast agents for myocardial perfusion imaging | Jun 20, 2017 | Issued |
Array
(
[id] => 12975718
[patent_doc_number] => 20170340656
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-11-30
[patent_title] => Non-Invasive Imaging Methods for Patient Selection for Treatment with Nanoparticulate Therapeutic Agents
[patent_app_type] => utility
[patent_app_number] => 15/622329
[patent_app_country] => US
[patent_app_date] => 2017-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7338
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15622329
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/622329 | Non-Invasive Imaging Methods for Patient Selection for Treatment with Nanoparticulate Therapeutic Agents | Jun 13, 2017 | Abandoned |
Array
(
[id] => 14435789
[patent_doc_number] => 20190175766
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-13
[patent_title] => STABILIZED CROSSLINKED NANOBUBBLES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 16/306840
[patent_app_country] => US
[patent_app_date] => 2017-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17969
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16306840
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/306840 | STABILIZED CROSSLINKED NANOBUBBLES FOR DIAGNOSTIC AND THERAPEUTIC APPLICATIONS | Jun 1, 2017 | Abandoned |
Array
(
[id] => 14498089
[patent_doc_number] => 20190192699
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-06-27
[patent_title] => NUCLEAR IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING CARBONIC ANHYDRASE IX AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/301338
[patent_app_country] => US
[patent_app_date] => 2017-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 25025
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 442
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16301338
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/301338 | NUCLEAR IMAGING AND RADIOTHERAPEUTICS AGENTS TARGETING CARBONIC ANHYDRASE IX AND USES THEREOF | May 11, 2017 | Abandoned |
Array
(
[id] => 16125783
[patent_doc_number] => 10696631
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents
[patent_app_type] => utility
[patent_app_number] => 16/099488
[patent_app_country] => US
[patent_app_date] => 2017-05-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 80
[patent_figures_cnt] => 117
[patent_no_of_words] => 14273
[patent_no_of_claims] => 46
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 168
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16099488
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/099488 | Chemical conjugates of evans blue derivatives and their use as radiotherapy and imaging agents | May 8, 2017 | Issued |
Array
(
[id] => 14609791
[patent_doc_number] => 10357574
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-23
[patent_title] => Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo
[patent_app_type] => utility
[patent_app_number] => 15/583197
[patent_app_country] => US
[patent_app_date] => 2017-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 31
[patent_no_of_words] => 10038
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 158
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15583197
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/583197 | Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo | Apr 30, 2017 | Issued |
Array
(
[id] => 12091347
[patent_doc_number] => 20170348441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-07
[patent_title] => 'THERAPY OF MALIGNANT NEOPLASIAS'
[patent_app_type] => utility
[patent_app_number] => 15/581916
[patent_app_country] => US
[patent_app_date] => 2017-04-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 9910
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15581916
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/581916 | THERAPY OF MALIGNANT NEOPLASIAS | Apr 27, 2017 | Abandoned |
Array
(
[id] => 14210831
[patent_doc_number] => 20190117800
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-04-25
[patent_title] => SYSTEMS AND METHODS FOR FILLING VIALS WITH GASES
[patent_app_type] => utility
[patent_app_number] => 16/093617
[patent_app_country] => US
[patent_app_date] => 2017-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4930
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16093617
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/093617 | SYSTEMS AND METHODS FOR FILLING VIALS WITH GASES | Apr 18, 2017 | Pending |
Array
(
[id] => 16831052
[patent_doc_number] => 11007283
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-05-18
[patent_title] => Contrast agents
[patent_app_type] => utility
[patent_app_number] => 16/092905
[patent_app_country] => US
[patent_app_date] => 2017-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16779
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16092905
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/092905 | Contrast agents | Apr 4, 2017 | Issued |
Array
(
[id] => 15928159
[patent_doc_number] => 20200155713
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-05-21
[patent_title] => PROSTATE-SPECIFIC MEMBRANE ANTIGEN TARGETED HIGH-AFFINITY AGENTS FOR ENDORADIOTHERAPY OF PROSTATE CANCER
[patent_app_type] => utility
[patent_app_number] => 16/087395
[patent_app_country] => US
[patent_app_date] => 2017-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13123
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16087395
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/087395 | Prostate-specific membrane antigen targeted high-affinity agents for endoradiotherapy of prostate cancer | Mar 21, 2017 | Issued |
Array
(
[id] => 19026354
[patent_doc_number] => 11925696
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-03-12
[patent_title] => Carbonic anhydrase IX targeting agents and methods
[patent_app_type] => utility
[patent_app_number] => 16/085393
[patent_app_country] => US
[patent_app_date] => 2017-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 30
[patent_no_of_words] => 20853
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16085393
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/085393 | Carbonic anhydrase IX targeting agents and methods | Mar 15, 2017 | Issued |